Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment

References

• Irvine GB, El-Agnaf OM, Shankar GM, Walsh DM. Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases. Mol Med 2008;14:451–464.
   PubMed Web of Science ®Google Scholar
• Jellinger KA. Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp?Acta Neuropathol 2009;117:101–110.
   PubMed Web of Science ®Google Scholar
• Werner P, Korczyn AD. Mild cognitive impairment: Conceptual, assessment, ethical, and social issues. Clin Interv Aging 2008;3:413–420.
   PubMed Web of Science ®Google Scholar
• Mancuso M, Nardini M, Micheli D, Rocchi A, Nesti C, Giglioli NJ, et al. Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany. Neurol Sci 2007;28:142–147.
   PubMedGoogle Scholar
• Tanzi RE. The genetics of Alzheimer disease. Cold Spring Harb Perspect Med 2012: a006296.
   PubMedGoogle Scholar
• Rogers JT, Lahiri DK. Metal and inflammatory targets for Alzheimer's disease. Curr Drug Targets 2004;5:535–551.
   PubMed Web of Science ®Google Scholar
• Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992;256:184–185.
   PubMed Web of Science ®Google Scholar
• Swerdlow RH, Khan SM. A “mitochondrial cascade hypothesis” for sporadic Alzheimer's disease. Med Hypotheses 2004; 63:8–20.
   PubMed Web of Science ®Google Scholar
• Petrozzi L, Ricci G, Giglioli NJ, Siciliano G, Mancuso M. Mitochondria and neurodegeneration. Biosci Rep 2007;27: 87–104.
   PubMed Web of Science ®Google Scholar
• Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1996;23:134–147.
   Google Scholar
• Corti A, De Tata V, Pompella A. Agenti e meccanismi di stress ossidativo nella patologia umana. Ligand Assay 2009;14:9–16.
   Google Scholar
• Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative Stress and Neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 2009;7:65–74.
   PubMed Web of Science ®Google Scholar
• Coppedè F, Migliore L. DNA damage and repair in Alzheimer's disease. Curr Alzheimer Res 2009;6:36–47.
   PubMed Web of Science ®Google Scholar
• Perry G, Cash AD, Smith MA. Alzheimer disease and oxidative stress. J Biomed Biotechnol 2002;2:120–123.
   PubMedGoogle Scholar
• Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res. 2007;35:7497–7504.
   PubMed Web of Science ®Google Scholar
• El-Bassyouni HT, Abdel Maksoud SA, Salem FA, Badr El-Deen R, Abdel Aziz H, Thomas MM. Evidence of oxidative stress in peroxisomal disorders. Singapore Med J 2012;53:608–614.
   PubMed Web of Science ®Google Scholar
• Siciliano G, Piazza S, Carlesi C, Del Corona A, Franzini M, Pompella A, et al. Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis. J Neurol 2007;254:575–580.
   PubMed Web of Science ®Google Scholar
• Dumont M, Beal MF. Neuroprotective strategies involving ROS in Alzheimer's disease. Free Radic Biol Med 2011; 51:1014–1026.
   PubMed Web of Science ®Google Scholar
• Puertas MC, Martínez-Martos JM, Cobo MP, Carrera MP, Mayas MD, Ramírez-Expósito MJ. Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia. Exp Gerontol 2012;47:625–630.
   PubMed Web of Science ®Google Scholar
• Casado A, Encarnación López-Fernández M, Concepción Casado M, de La Torre R. Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochem Res 2008;33:450–458.
   PubMed Web of Science ®Google Scholar
• Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, Stefanescu C. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2010;469:6–10.
   PubMed Web of Science ®Google Scholar
• Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr 2000;71:621S–629S.
   PubMed Web of Science ®Google Scholar
• Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 1996;14:55–61.
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304–1313.
   PubMed Web of Science ®Google Scholar
• Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay. Anal Biochem 1996;239:70–76.
   PubMed Web of Science ®Google Scholar
• Baldeiras I, Santana I, Proença MT, Garrucho MH, Pascoal R, Rodrigues A, et al. Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment. J Alzheimers Dis 2010 [Epub ahead of print].
   PubMedGoogle Scholar
• Butterfield DA, Reed T, Newman SF, Sultana R. Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 2007; 43:658–677.
   PubMed Web of Science ®Google Scholar
• Feng Y, Wang X. Antioxidant Therapies for Alzheimer's Disease. Oxid Med Cell Longev 2012;1–17.
   Google Scholar
• Butterfield DA. Oxidative stress in Alzheimer disease: synergy between the butterfield and markesbery laboratories. Neuromolecular Med 2011;13:19–22.
   PubMed Web of Science ®Google Scholar
• Addabbo F, Montagnani M, Goligorsky MS. Mitochondria and reactive oxygen species. Hypertension 2009;53885–892. Review. No abstract available.
   Google Scholar
• Yan MH, Wang X, Zhu X. Mitochondrial defects and oxidative stress in Alzheimer's disease and Parkinson's disease. Free Radic Biol Med 2012;S0891– 5849(12)01823–0.
   Google Scholar
• Govoni S, Pelosi C, Racchi M. Oxidative stress, aging and dementia: the uncertain boundaries of a biological continuum difficult to assess. Dementia update 2001;10:4–10.
   Google Scholar
• Piwowar A. Advanced oxidation protein products. Part I. Mechanism of the formation, characteristics and property. Pol Merkur Lekarski 2010;28:166–169.
   PubMedGoogle Scholar
• Jansen EHJM, Ruskovska T. Comparative analysis of serum (Anti)oxidative status parаmeters in healthy persons. Int J Mol Sci 2013;14:6106–6115.
   PubMed Web of Science ®Google Scholar
• Serra JA, Domínguez RO, de Lustig ES, Guareschi EM, Famulari AL, Bartolomé EL, Marschoff ER. Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients. J Neural Transm 2001; 108:1135–1148.
   PubMed Web of Science ®Google Scholar
• Guidi I, Galimberti D, Lonati S, Novembrino C, Bamonti F, Tiriticco M, et al. Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's Disease. Neurobiol Aging 2006;27:262–269.
   PubMedGoogle Scholar
• Zafrilla P, Mulero J, Xandri JM, Santo E, Caravaca G, Morillas JM. Oxidative stress in Alzheimer patients in different stages of the disease. Curr Med Chem 2006;13: 1075–1083.
   PubMedGoogle Scholar
• Sekler A, Jiménez JM, Rojo L, Pastene E, Fuentes P, Slachevsky A, Maccioni RB. Cognitive impairment and Alzheimer's disease: Links with oxidative stress and cholesterol metabolism. Neuropsychiatr Dis Treat 2008;4:715–722.
   PubMedGoogle Scholar
• Sultana R, Piroddi M, Galli F, Butterfield DA. Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment. Neurochem Res 2008;33:2540–2546.
   PubMed Web of Science ®Google Scholar
• Ahmad A, Shameem M, Husain Q. Relation of oxidant- antioxidant imbalance with disease progression in patients with asthma. Ann Thorac Med 2012;7:226–232.
   PubMed Web of Science ®Google Scholar
• Ihara Y, Hayabara T, Sasaki K, Kawada R, Nakashima Y, Kuroda S. Relationship between oxidative stress and apoE phenotype in Alzheimer's disease. Acta Neurol Scand 2000;102:346–349.
   PubMedGoogle Scholar
• Ramassamy C, Averill D, Beffert U, Bastianetto S, Theroux L, Lussier-Cacan S, et al. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radic Biol Med. 1999;27:544–553.
   PubMed Web of Science ®Google Scholar
• Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 2007;68:1588–1595.
   PubMed Web of Science ®Google Scholar
• Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, et al. Predictive utility of Apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Arch Neurol 2005;62:975–980.
   PubMedGoogle Scholar
• Kryscio RJ, Schmitt FA, Salazar JC, Mendiondo MS, Markesbery WR. Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology 2006; 66:828–832.
   PubMed Web of Science ®Google Scholar
• Visser PJ, Verhey FRJ, Ponds RWHM, Cruts M, van Broeckhoven CL, Jolles J. Course of objective memory impairment in non-demented subjects attending a memory clinic and predictors of outcome. Int J Geriatr Psychiatry 2000;15:363–372.
   PubMedGoogle Scholar
• de-Almada BV, de-Almeida LD, Camporez D, de-Moraes MV, Morelato RL, Perrone AM, et al. Protective effect of the APOE-e3 allele in Alzheimer's disease. Braz J Med Biol Res 2012;45:8–12.
   PubMed Web of Science ®Google Scholar
• Leininger-Muller B, Jolivalt C, Bertrand P, Siest G. Oxidation of human apolipoprotein E: isoforms susceptibility and protection with Ginkgo biloba EGb 761 extract. In: Packer L, Christen Y (eds.). Ginkgo Biloba Extract (EGb 761) Study: Lessons from Cell Biology. Paris: Elsevier; 1998. pp. 57–68.
   Google Scholar